M edical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results , with sales up 6.6% year on year to $657.3 million. The company expects the full year’s revenue to be around $2.68 ...

Following the consummation of the Nevro, Inc. acquisition, which we expect to close in the late second quarter of 2025, Globus Medical anticipates 2025 net sales of $2.80 billion to $2.90 billion ...

Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve ...

This surpassed our model’s projection of $511.8 million in sales from this region. Globus Medical, Inc. Price, Consensus and EPS Surprise Globus Medical, Inc. Price, Consensus and EPS Surprise ...

Globus Medical, Inc. GMED continues to benefit from ... In the fourth quarter, Globus' musculoskeletal sales improved 4.5% year over year. The growth was driven primarily by strong contributions ...

Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “hold” rating restated by equities researchers at Needham & ...